Skip to main content
Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.790
-0.020 (-0.52%)
Apr 29, 2026, 1:42 PM CET

Scandinavian ChemoTech AB Revenue

Scandinavian ChemoTech AB had revenue of 2.97M SEK in the quarter ending March 31, 2026, with 20.11% growth. This brings the company's revenue in the last twelve months to 12.74M, up 65.63% year-over-year. In the year 2025, Scandinavian ChemoTech AB had annual revenue of 12.29M with 87.10% growth.

Revenue (ttm)
12.74M
Revenue Growth
+65.63%
P/S Ratio
7.89
Revenue / Employee
12.29M
Employees
1
Market Cap
96.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202512.29M5.72M87.10%
Dec 31, 20246.57M3.74M132.67%
Dec 31, 20232.82M2.35M496.62%
Dec 31, 2022473.00K-2.11M-81.70%
Dec 31, 20212.59M1.17M82.81%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biovica International AB 10.93M
Magle Chemoswed Holding AB 287.55M
Simris Group AB (PUBL) 1.62M
OncoZenge AB 2.78M
AcouSort AB 10.43M
Spago Nanomedical AB 4.82M
IRLAB Therapeutics AB 57.46M
NextCell Pharma AB 9.83M
Revenue Rankings

Scandinavian ChemoTech AB News

More News